Real‐world <i>EGFR</i> testing in patients with stage IIIB/IV non‐small‐cell lung cancer in North China: A multicenter, non‐interventional studyYing Cheng, Bing Li, Yan Wang et al.|Thoracic Cancer|2018Cited by 37
Efficacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC: A Multicenter, Single-Arm, Phase 2b StudyYuankai Shi, Tingting Song, Baolan Li et al.|Journal of Thoracic Oncology|2022Cited by 29
P79.02 Updated OS and Time to Second Progression with First-Line Camrelizumab Plus Chemo vs Chemo for Advanced Non-Squamous NSCLCC. Zhou, Chengping Hu, Jianxiang Shi et al.|Journal of Thoracic Oncology|2021Cited by 7
Efficacy and safety of ASK120067 (limertinib) in patients with locally advanced or metastatic EGFR T790M-mutated non–small cell lung cancer: A multicenter, single-arm, phase IIb study.Baolan Li, Yuankai Shi, Lin Wu et al.|Journal of Clinical Oncology|2022Cited by 3